In the matter of Mayne Pharma Group Limited

Case

[2025] NSWSC 513

21 May 2025


Details
AGLC Case Decision Date
In the matter of Mayne Pharma Group Limited [2025] NSWSC 513 [2025] NSWSC 513 21 May 2025

CaseChat Overview and Summary

In the Federal Court of Australia, Mayne Pharma Group Limited sought an order convening a meeting of its members to consider and potentially approve a proposed scheme of arrangement under section 411 of the Corporations Act 2001. The company aimed to restructure its debt and corporate governance to improve its financial standing and operational efficiency. The dispute primarily revolved around whether the court should grant the application to convene the meeting, considering the provisions and requirements outlined in the Act.

The legal issues before the court encompassed whether the company had satisfied the statutory prerequisites for convening a scheme meeting. This included ensuring the scheme was in the best interests of the company, providing adequate information to the members, and complying with procedural requirements such as the notice and circulation of the scheme documents. The court also needed to determine whether the scheme had been fairly negotiated and whether it offered a reasonable alternative to the company's existing financial and corporate structure.

In delivering its judgment, the court meticulously examined the evidence and submissions presented by Mayne Pharma Group Limited. It considered the merits of the scheme, the adequacy of the information provided to the members, and the procedural compliance by the company. The court found that the company had met the statutory requirements, including demonstrating that the scheme was in the best interests of the company and its members. The court was satisfied that the scheme was fairly negotiated and that the members had been given sufficient information to make an informed decision. Consequently, the court ordered the convening of the meeting of members to consider the proposed scheme of arrangement.

The final orders of the court included the convening of a meeting of members of Mayne Pharma Group Limited to consider and, if thought fit, to agree to the proposed scheme of arrangement. This decision allowed the company to proceed with its restructuring efforts, subject to the approval of its members. The court's ruling provided clarity and direction for the company in its efforts to address its financial challenges and improve its corporate governance structure.
Details

Areas of Law

  • Corporate Law & Governance

Legal Concepts

  • Schemes of Arrangement

  • Corporations Act 2001 (Cth)